Unser Team und unsere Praxis

Friedrich K, Smit M, Brune M, Giese T, Rupp C, Wannhoff A, Kloeters P, Leopold Y, Denk GU,  Weiss KH, Strem­mel W, Sauer P, Hohen­ester S, Schir­ma­ch­er P, Schem­mer P, Got­thardt DN. CD14 is asso­ci­at­ed with bil­iary stric­ture for­ma­tion. Hepa­tol­ogy. 2016;10.1002/hep.28543

Friedrich K., Smit M., Wannhoff A., Rupp C., Scholl S., Antoni C., Dollinger M., Neu­mann-Hae­fe­lin C., Strem­mel W., Weiss K.H., Schem­mer P., Got­thardt D.N. Cof­fee con­sump­tion pro­tects against pro­gres­sion in liv­er cir­rho­sis and increas­es long-term sur­vival after liv­er trans­plan­ta­tion. J Gas­troen­terol Hepa­tol. 2016, accept­ed for publication

Friedrich K, Bau­mann C, Brune M, Wannhoff A, Rupp C, Scholl SG, Antoni C, Dollinger M, Neu­mann-Hae­fe­lin C, Weiss KH, Strem­mel W, Schem­mer P, Got­thardt DN. Asso­ci­a­tion of serum zinc lev­els with liv­er func­tion and sur­vival in patients await­ing liv­er trans­plan­ta­tion. Lan­gen­becks Arch Surg. 2015 Oct;400(7):805–11. doi: 10.1007/s00423-015‑1334‑7. Epub 2015 Aug 26.

Friedrich K, Nüssle S, Rehlen T, Strem­mel W, Mis­chnik A, Eisen­bach C.Microbiology and resistence in first episodes of spon­ta­neous bac­te­r­i­al peri­toni­tis: impli­ca­tions for man­age­ment and prog­no­sis. J Gas­troen­terol Hepa­tol. 2015 Dec 17. doi: 10.1111/jgh.13266. [Epub ahead of print] 

Friedrich K, Rupp C, Hov JR, Steine­brun­ner N, Weiss KH, Stiehl A, Brune M, Schae­fer PK, Schem­mer P, Sauer P, Schir­ma­ch­er P, Runz H, Karlsen TH, Strem­mel W, Got­thardt DN. A fre­quent PNPLA3 vari­ant is a sex spe­cif­ic dis­ease mod­i­fi­er in PSC patients with bile duct steno­sis. PLoS One. 2013;8(3):e58734

Friedrich K, Wannhoff A, Kat­tner S, Brune M, Hov JR, Weiss KH, Antoni C, Dollinger M, Neu­mann-Hae­fe­lin C, Seuf­fer­lein T, Schem­mer P, Schir­ma­ch­er P, Strem­mel W, Got­thardt DN. PNPLA3 in end-stage liv­er dis­ease: alco­hol con­sump­tion, hepa­to­cel­lu­lar car­ci­no­ma devel­op­ment, and trans­plan­ta­tion-free sur­vival. J Gas­troen­terol Hepa­tol. 2014;29(7):1477–84

Friedrich K. and Strem­mel W. Anes­the­si­ol­o­gist-admin­is­tered gas­troin­testi­nal seda­tion: time to put it to sleep? Diges­tive Dis­ease and Sci­ences. 2015 Sep;60(9):2566–7. doi: 10.1007/s10620-015‑3703‑z. Epub 2015 May 19.

Friedrich K, Strem­mel W, Sieg A. Endo­scopist-admin­is­tered propo­fol seda­tion is safe – a prospec­tive eval­u­a­tion of 10,000 patients in an out­pa­tient prac­tice. J Gas­troin­testin Liv­er Dis. 2012 Sep;21(3):259–63

Sieg A; bng-Study-Group, Beck S, Scholl SG, Heil FJ, Got­thardt DN, Strem­mel W, Rex DK, Friedrich K. Safe­ty analy­sis of endo­scopist-direct­ed propo­fol seda­tion: a prospec­tive, nation­al mul­ti­cen­ter study of 24 441 patients in Ger­man out­pa­tient prac­tices. J Gas­troen­terol Hepa­tol. 2014 Mar;29(3):517–23.

Friedrich K, Scholl SG, Beck S, Got­thardt D, Strem­mel W, Rex DK; bng-Study-Group, Sieg A. Res­pi­ra­to­ry com­pli­ca­tions in out­pa­tient endoscopy with endo­scopist-direct­ed seda­tion. J Gas­troin­testin Liv­er Dis. 2014 Sep;23(3):255–9

Friedrich K, Grüter L, Got­thardt D, Eisen­bach C, Strem­mel W,

Scholl S, Rex DK, Sieg A. Sur­vival in patients with col­orec­tal can­cer diag­nosed by screen­ing colonoscopy. Gas­troin­test Endosc. 2015 Jul;82(1):133–7. doi: 10.1016/j.gie.2014.12.048. Epub 2015 May 16.

Friedrich K, Gehrke S, Strem­mel W, Sieg A. First clin­i­cal tri­al of a new­ly devel­oped cap­sule endo­scope with panoram­ic side view for small bow­el: a pilot study. J Gas­troen­terol Hepa­tol. 2013 Sep;28(9):1496–501. J Gas­troen Hepatol

Sieg A, Friedrich K, Sieg U. Is Pill­Cam COLON cap­sule endoscopy ready for col­orec­tal can­cer screen­ing? A prospec­tive fea­si­bil­i­ty study in a com­mu­ni­ty gas­troen­terol­o­gy prac­tice. Am J Gas­troen­terol. 2009 Apr;104(4):848–54.

Wannhoff A, Hov JR, Folser­aas T, Rupp C, Friedrich K, Anmarkrud JA, Weiss KH, Sauer P, Schir­ma­ch­er P, Boberg KM, Strem­mel W, Karlsen TH, Got­thardt DN. FUT2 and FUT3 geno­type deter­mines CA19‑9 cut-off val­ues for detec­tion of cholan­gio­car­ci­no­ma in patients with pri­ma­ry scle­ros­ing cholan­gi­tis. J Hepa­tol. 2013 Dec;59(6):1278–84.

Wannhoff A, Rupp C, Friedrich K, Brune M, Knier­im J, Flecht­en­mach­er C, Sauer P, Strem­mel W, Hov JR, Schir­ma­ch­er P, Weiss KH, Got­thardt DN.Inflammation But Not Bil­iary Obstruc­tion Is Asso­ci­at­ed With Car­bo­hy­drate Anti­gen 19–9 Lev­els in Patients With Pri­ma­ry Scle­ros­ing Cholan­gi­tis. Clin Gas­troen­terol Hepa­tol. 2015 Dec;13(13):2372–9. doi: 10.1016/j.cgh.2015.07.014. Epub 2015 Jul 17.

Jones A, Friedrich K, Rohm M, Schäfer M, Algire C, Kulozik P, Seib­ert O, Müller-Deck­er K, Sij­mon­s­ma T, Str­zo­da D, Sticht C, Gretz N, Dallinga-Thie GM, Leuchs B, Kögl M, Strem­mel W, Diaz MB, Herzig S. TSC22D4 is a mol­e­c­u­lar out­put of hepat­ic wast­ing metab­o­lism. EMBO Mol Med. 2013 Feb;5(2):294–308.

Völk­ers M, Doroudgar S, Nguyen N, Kon­standin MH, Qui­ja­da P, Din S, Ornelas L, Thuer­auf DJ, Gude N, Friedrich K, Herzig S, Glem­bot­s­ki CC, Suss­man MA. PRAS40 pre­vents devel­op­ment of dia­bet­ic car­diomy­opa­thy and improves hepat­ic insulin sen­si­tiv­i­ty in obe­si­ty. EMBO Mol Med. 2014 Jan;6(1):57–65

Rupp C, Rössler A, Hal­iba­sic E, Sauer P, Weiss KH, Friedrich K, Wannhoff A, Stiehl A, Strem­mel W, Trauner M, Got­thardt DN. Reduc­tion in alka­line phos­phatase is asso­ci­at­ed with longer sur­vival in pri­ma­ry scle­ros­ing cholan­gi­tis, inde­pen­dent of dom­i­nant steno­sis. Ali­ment Phar­ma­col Ther. 2014 Dec;40(11–12):1292–301.

Rupp C, Friedrich K, Folser­aas T, Wannhoff A, Bode KA, Weiss KH, Schir­ma­ch­er P, Sauer P, Strem­mel W, Got­thardt DN. Fut2 geno­type is a risk fac­tor for dom­i­nant steno­sis and bil­iary can­di­da infec­tions in pri­ma­ry scle­ros­ing cholan­gi­tis. Ali­ment Phar­ma­col Ther. 2014 Apr;39(8):873–82.

Wannhoff A, Müller OJ, Friedrich K, Rupp C, Klöters-Plachky P, Leopold Y, Brune M, Sen­ner M, Weiss KH, Strem­mel W, Schem­mer P, Katus HA, Got­thardt DN. Effects of increased von Wille­brand fac­tor lev­els on pri­ma­ry hemo­sta­sis in throm­bo­cy­topenic patients with liv­er cir­rho­sis. PLoS One. 2014 Nov 14;9(11):e112583

Rupp C, Bode KA, Cha­houd F, Wannhoff A, Friedrich K, Weiss KH, Sauer P, Strem­mel W, Got­thardt DN. Risk fac­tors and out­come in patients with pri­ma­ry scle­ros­ing cholan­gi­tis with per­sis­tent bil­iary can­didi­a­sis. BMC Infect Dis. 2014 Oct 23;14:562

Stre­ich NA, Friedrich K, Got­ter­barm T, Schmitt H.Recon­struc­tion of the ACL with a semi­tendi­nosus ten­don graft: a prospec­tive ran­dom­ized sin­gle blind­ed com­par­i­son of dou­ble-bun­dle ver­sus sin­gle-bun­dle tech­nique in male ath­letes. Knee Surg Sports Trau­ma­tol Arthrosc. 2008 Mar;16(3):232–8.

Sieg A, Friedrich K. Per­spec­tives of col­orec­tal can­cer screen­ing in Ger­many 2009.

World J Gas­troin­test Endosc. 2009 Oct 15;1(1):12–6

Friedrich K. and Got­thardt DN. Die Lebertransplantation.
Thieme CNE.fortbildung 05:2013; 7–10. (IF: 0)

Sieg A, Friedrich K. Eine neue Kapsel mit 360 Grad Rundumsicht
Z Gas­troen­terol, Aus­gabe 10 · Vol­ume 51 · Okto­ber 2013